Merkley Wins Prevacid

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK — Merkley Newman Harty & Partners has been selected to handle ad duties on Prevacid, a heartburn drug from TAP Pharmaceutical Products, the client confirmed. Billings are estimated at $100 million.

The New York shop, a unit of Omnicom Group, bested the Interpublic Group team of McCann-Erickson in New York and Gillespie in Princeton, N.J., said sources. (Gillespie previously handled the brand on a project basis.)

Merkley could not be reached and a representative of the Lake Forest, Ill.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in